TF overexpression has been reported in ovarian cancer [160], endometriosis [161], breast cancer [162], nonsmall cell lung carcinoma [163], prostate cancer [164], pancreatic cancer [165], melanoma [166], colorectal cancer [167], gastric cancer [168], esophageal cancer [169], hepatocellular carcinoma [170], brain tumor glioblastoma [171], leukemia [172], and lymphoma [173]. This evidence concerns the gene TF and breast cancer.